This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
This is a prospective, multi-center, observational nonsignificant risk study aimed to collect blood and clinical data from primary lung cancer and control subjects to characterize various biomarkers that will discriminate between lung cancer and control subjects.
Study Type
OBSERVATIONAL
Enrollment
6,000
Blood collection
Life Spring Clinical Research
Miami, Florida, United States
RECRUITINGEmerald Coast OBGYN
Panama City, Florida, United States
RECRUITINGPerformance
Performance of the assay in terms of (1) Sensitivity (2) Specificity (3) NPV (negative predictive value) and (4) PPV (positive predictive value).
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Ochsner LSU Health Shreveport - Regional Urology
Shreveport, Louisiana, United States
Comprehensive Urology
Southfield, Michigan, United States
COMPLETEDMichigan Institute of Urology, P.C.
Troy, Michigan, United States
RECRUITINGUrology San Antonio
San Antonio, Texas, United States
RECRUITINGNational Koranyi Institute for Pulmonology
Budapest, Hungary
RECRUITINGCarmel Medical Center
Haifa, Israel
RECRUITINGSourasky Medical Center
Tel Aviv, Israel
RECRUITINGZGT Medical Center
Hengelo, Netherlands
RECRUITING